Baysal, AyseSagiroglu, GonulDogukan, MevlutOzkaynak, Ismail2024-06-122024-06-1220221089-94721532-8473https://hdl.handle.net/20.500.14551/25351dose after neostigmine a routine reversal may prevent residual neuoutcome parameter of incidence of rNMB with other clinical studies may show external validity issues. In the Letter to the Editor, the authors have a request to explain these comparisons with other clinical studies; (3) The Letter to the Editor suggested that although their primary endpoint was the incidence of a train-of-four (TOF) ratio less than 0.9 at tracheal extubation, Baysal and her colleagues did not use TOF monitoring for extubation of the patients in their clinical study. They used only clinically apparent diaphragmatic movements for extubation. The authors of the Letter to the Editor, Neira-Somoza the administration of a lower dose of sugammadex to displace the use of neostigmine with a lower dose and earlier administration of sugammadex which is another future investigation of neuromuscular reversal agents.eninfo:eu-repo/semantics/closedAccessResidual Neuromuscular BlockadeMulticenterLetter375584585Q3WOS:00086914170000536182245